Plasma and cerebrospinal fluid pharmacokinetics of the Akt inhibitor, perifosine, in a non‑human primate model

Documenti analoghi

• Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates
  di: Shah, Nirali N., et al.
  Pubblicazione: (2015)
• The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates
  di: Kim, AeRang, et al.
  Pubblicazione: (2010)
• TRTH-33. COMPARATIVE PLASMA AND CEREBROSPINAL FLUID PHARMACOKINETICS OF BRAF AND MEK INHIBITORS IN A NONHUMAN PRIMATE MODEL
  di: Rodgers, Louis, et al.
  Pubblicazione: (2017)
• The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates
  di: Marcus, Leigh, et al.
  Pubblicazione: (2011)
• Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models
  di: Lester McCully, Cynthia, et al.
  Pubblicazione: (2020)